# Study of CS-3150 in Patients With Primary Aldosteronism

> **NCT02885662** · NA · COMPLETED · sponsor: **Daiichi Sankyo Co., Ltd.** · enrollment: 44 (actual)

## Conditions studied

- Primary Aldosteronism

## Interventions

- **DRUG:** CS-3150

## Key facts

- **NCT ID:** NCT02885662
- **Lead sponsor:** Daiichi Sankyo Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09
- **Primary completion:** 2017-07-20
- **Final completion:** 2017-07-20
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2018-12-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02885662

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02885662, "Study of CS-3150 in Patients With Primary Aldosteronism". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT02885662. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*